Novel spirodihydrobenzofuranlactams as antagonists of endothelin and as inhibitors of HIV-1 protease produced by Stachybotrys sp. II. Structure determination. 1996

B E Roggo, and P Hug, and S Moss, and A Stämpfli, and H P Kriemler, and H H Peter
Core Drug Discovery Technologies, Pharmaceutical Division, Ciba-Geigy Limited, Basel, Switzerland.

UI MeSH Term Description Entries
D007769 Lactams Cyclic AMIDES formed from aminocarboxylic acids by the elimination of water. Lactims are the enol forms of lactams. Lactam,Lactim,Lactims
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001572 Benzofurans Compounds that contain a BENZENE ring fused to a furan ring. Coumarones,Diphenylbenzofuran
D013141 Spiro Compounds Cyclic compounds that include two rings which share a single atom (usually a carbon). The simplest example of this type of compound is Spiro[2.2]pentane, which looks like a bow tie. Compounds, Spiro
D013191 Stachybotrys A mitosporic fungal genus including one species which forms a toxin in moldy hay that may cause a serious illness in horses. Stachybotry
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D016232 Endothelins 21-Amino-acid peptides produced by vascular endothelial cells and functioning as potent vasoconstrictors. The endothelin family consists of three members, ENDOTHELIN-1; ENDOTHELIN-2; and ENDOTHELIN-3. All three peptides contain 21 amino acids, but vary in amino acid composition. The three peptides produce vasoconstrictor and pressor responses in various parts of the body. However, the quantitative profiles of the pharmacological activities are considerably different among the three isopeptides. Endothelium-Derived Vasoconstrictor Factors,Endothelin,Vasoconstrictor Factors, Endothelium-Derived
D016333 HIV Protease Enzyme of the human immunodeficiency virus that is required for post-translational cleavage of gag and gag-pol precursor polyproteins into functional products needed for viral assembly. HIV protease is an aspartic protease encoded by the amino terminus of the pol gene. HIV Proteinase,HTLV-III Protease,p16 pol gene product, HIV,p16 protease, HIV,HIV p16 protease,HTLV III Protease,Protease, HIV,Protease, HTLV-III

Related Publications

B E Roggo, and P Hug, and S Moss, and A Stämpfli, and H P Kriemler, and H H Peter
January 1996, The Journal of antibiotics,
B E Roggo, and P Hug, and S Moss, and A Stämpfli, and H P Kriemler, and H H Peter
December 1995, The Journal of antibiotics,
B E Roggo, and P Hug, and S Moss, and A Stämpfli, and H P Kriemler, and H H Peter
December 1995, The Journal of antibiotics,
B E Roggo, and P Hug, and S Moss, and A Stämpfli, and H P Kriemler, and H H Peter
June 1994, The Journal of antibiotics,
B E Roggo, and P Hug, and S Moss, and A Stämpfli, and H P Kriemler, and H H Peter
January 1996, The Journal of antibiotics,
B E Roggo, and P Hug, and S Moss, and A Stämpfli, and H P Kriemler, and H H Peter
November 1992, The Journal of antibiotics,
B E Roggo, and P Hug, and S Moss, and A Stämpfli, and H P Kriemler, and H H Peter
December 1995, The Journal of antibiotics,
B E Roggo, and P Hug, and S Moss, and A Stämpfli, and H P Kriemler, and H H Peter
April 1995, The Journal of antibiotics,
B E Roggo, and P Hug, and S Moss, and A Stämpfli, and H P Kriemler, and H H Peter
January 1993, The Journal of antibiotics,
B E Roggo, and P Hug, and S Moss, and A Stämpfli, and H P Kriemler, and H H Peter
August 1997, The Journal of antibiotics,
Copied contents to your clipboard!